microdosing glp-1 menopause Jill Microdosing GLP-1s: A Doctor's Guide
Description
doi: 10.1016/j.jep.2004.12.010 240 AderibigbeAOEmudianugheTSLawalBS
It does not compete directly on maximum weight loss with injectable multi-receptor agonists but instead offers a differentiated value proposition based on oral convenience, no restrictions, lower manufacturing costs, and the potential to dramatically expand the addressable patient population for GLP-1 therapy
How is this extra weight affecting you and your day-to-day activities
Its important to consult with your healthcare provider to determine if Semaglutide GLP-1 is the right option for you, weighing all potential benefits and risks
( 10.1016/j.molmet.2021.101351) [DOI] [PMC free article] [PubMed] [Google Scholar] Drucker DJ & Holst JJ
Published 2024 Oct 17
